+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Apixaban - Global Strategic Business Report - Product Thumbnail Image

Apixaban - Global Strategic Business Report

  • Report
  • September 2025
  • 282 Pages
  • Global
From
Venous Thromboembolism Treatment - Global Strategic Business Report - Product Thumbnail Image

Venous Thromboembolism Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 384 Pages
  • Global
From
Albendazole Veterinary - Global Strategic Business Report - Product Thumbnail Image

Albendazole Veterinary - Global Strategic Business Report

  • Report
  • September 2025
  • 383 Pages
  • Global
From
Malaria Treatment - Global Strategic Business Report - Product Thumbnail Image

Malaria Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 372 Pages
  • Global
From
Menstrual Drugs - Global Strategic Business Report - Product Thumbnail Image

Menstrual Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 290 Pages
  • Global
From
Menstrual Pain Relief Devices - Global Strategic Business Report - Product Thumbnail Image

Menstrual Pain Relief Devices - Global Strategic Business Report

  • Report
  • September 2025
  • 392 Pages
  • Global
From
From
Spasticity Treatment - Global Strategic Business Report - Product Thumbnail Image

Spasticity Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 334 Pages
  • Global
From
Tardive Dyskinesia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Tardive Dyskinesia Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 240 Pages
  • Global
From
Tourettes Syndrome Drugs - Global Strategic Business Report - Product Thumbnail Image

Tourettes Syndrome Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 274 Pages
  • Global
From
Troponin - Global Strategic Business Report - Product Thumbnail Image

Troponin - Global Strategic Business Report

  • Report
  • September 2025
  • 290 Pages
  • Global
From
Tumor-Induced Osteomalacia - Global Strategic Business Report - Product Thumbnail Image

Tumor-Induced Osteomalacia - Global Strategic Business Report

  • Report
  • September 2025
  • 281 Pages
  • Global
From
From
Usher Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Usher Syndrome Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 392 Pages
  • Global
From
Vertigo Drugs - Global Strategic Business Report - Product Thumbnail Image

Vertigo Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 267 Pages
  • Global
From
Vitiligo Treatment - Global Strategic Business Report - Product Thumbnail Image

Vitiligo Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 377 Pages
  • Global
From
Hemangioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Hemangioma Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 485 Pages
  • Global
From
From
Human Immunoglobulin - Global Strategic Business Report - Product Thumbnail Image

Human Immunoglobulin - Global Strategic Business Report

  • Report
  • September 2025
  • 279 Pages
  • Global
From
Hydroxyzine - Global Strategic Business Report - Product Thumbnail Image

Hydroxyzine - Global Strategic Business Report

  • Report
  • September 2025
  • 284 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more